LEDAZEROL
UNII P13OO3FPZB

Substance Identification & Data

This profile provides standardized clinical and technical data for Ledazerol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P13OO3FPZB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 116795-97-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P13OO3FPZB

CAS Registry Number

116795-97-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEDAZEROL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C11H12N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PGVXBSSEVQUMQM-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81348

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

65932

Unique identification number in the NCBI database of chemical substances.

INN ID

6619

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[nH]1cncc1Cc2c(c(ccc2)CO)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ledazerol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.